Clinical Trial Update: Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal Women [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety and effects of Garetosmab in healthy obese men and postmenopausal women has been withdrawn. The study was sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Garetosmab (Garetosmab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Obesity | Phase 1 | Status: WITHDRAWN